Ultralife Reports Q1 Net Loss and Revenue Decline Amid Operational Challenges; Backlog Hits Record High

summarizeSummary

Ultralife Corporation reported a net loss of $0.03 per share and a 6.5% revenue decline to $47.4 million for Q1 2026, down from a profit of $0.11 per share and $50.7 million in Q1 2025, citing production issues and weak sales, though backlog reached a record $115.1 million.

check_boxKey Events

• Q1 Revenue Decline

  Total revenues decreased by 6.5% year-over-year to $47.4 million for the first quarter of 2026, down from $50.7 million in Q1 2025. Battery & Energy Products sales fell 4.7%, and Communications Systems sales dropped 25.7%.

• Shift to Net Loss

  The company reported a GAAP net loss of ($0.03) per basic and diluted share for Q1 2026, a significant reversal from net income of $0.11 per share in the prior-year period.

• Operating Loss and Margin Compression

  Operating income turned into an operating loss of ($0.2) million in Q1 2026, compared to income of $3.4 million in Q1 2025. Gross profit margin compressed to 21.3% from 25.1% year-over-year, impacted by product mix, higher utility costs, and production inefficiencies.

• Record Backlog Achieved

  Despite the weak quarterly performance, Ultralife's backlog reached a record $115.1 million at quarter-end, up from $110.2 million exiting Q4 2025 and $95.0 million in Q1 2025, reflecting long-sales cycle orders for new products.

auto_awesomeAnalysis

Ultralife Corporation reported a significant deterioration in its first-quarter financial performance, with revenue declining and the company shifting from an operating profit to a loss, and positive GAAP EPS to a net loss. This follows a Reuters report earlier today summarizing the top-line figures. Management attributed the poor results to various operational challenges, including production days lost due to a power outage, inventory integration activities, inclement weather, and continued weakness in Communications Systems sales. Despite these setbacks, the company achieved a record-high backlog of $115.1 million, suggesting potential for future revenue. Investors will be watching for signs of improved manufacturing efficiencies and order fulfillment in subsequent quarters to restore profitability and leverage the growing backlog.